Skip to Main Content

Paper Details

Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.
Nucleic Acids Res
2
2023
PCa, PCa GWAS risk regions, enhancer, enhancer elements, interacting genes, loci, non-coding genetic variants, non-coding regions, non-coding variants, prostate cancer, single nucleotide polymorphisms
Author NameAffiliation
Sylvan C BacaThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Dennis GrishinThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Faraz Hach
Faraz HachUniversity of British Columbia
Alexander GusevThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Alexander GusevHarvard T.H. Chan School of Public Health
Alexander GusevThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Alexander GusevHarvard T.H. Chan School of Public Health
Matthew L FreedmanThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Matthew L FreedmanThe Center for Cancer Genome Discovery, Dana Farber Cancer Institute
Matthew L FreedmanThe Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute
Matthew L FreedmanThe Center for Cancer Genome Discovery, Dana Farber Cancer Institute
Bogdan PasaniucUniversity of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucUniversity of California los angeles
Bogdan PasaniucUniversity of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucDavid Geffen School of Medicine, University of California los angeles
Bogdan PasaniucUniversity of California los angeles
  • 1 - 20

Datasets